cell cell
Associate Professor Scott Wallace 
Dell School of Medicine, University of Texas at Austin, USA


Scott Wallace plays an influential part in the transformation of America’s health delivery. Leveraging his business and health policy background, he works in the U.S. and around the world with employers, health care providers, health plans, governments and others to develop new health benefit and care models to improve health, stop the progression of chronic diseases and effectively treat patients’ medical conditions.

A Batten Fellow at the University of Virginia’s Darden School of Business, Wallace is currently an associate professor and core part of the inaugural faculty at the University of Texas at Austin’s Dell Medical School, a pioneering, value-based medical school. He also served on the faculty for Harvard Business School’s executive education program on health care strategy, and most recently, was a Distinguished Fellow at the Geisel School of Medicine at Dartmouth, where he helped to create its masters in health care delivery science program, an innovative new course for mid-career executives and clinicians from across the U.S. and more than 15 countries.

In collaboration with Elizabeth Teisberg – a leading expert on value creation and its integral role in improving service delivery in health care – Wallace also teaches workshops on value-based health care delivery using a new case model they developed together, including the proprietary Experience Group research tool. The expert duo – also co-authors of a forthcoming book, “Capability, Comfort and Calm: Designing Health Care Services for Excellence and Empathy” –deliver custom content programs onsite, a significant differentiator from typical executive education platforms.

Wallace’s work across the health care sector is wide-ranging and far-reaching. He is currently advising a leading hospital system in the U.S. mountain west to develop functional outcome measures of care. By using condition-specific outcome measures, the goals of patients and providers are more tightly aligned, with caregivers measured on aspects of their professional results rather than process compliance and hotel-like measures of patient satisfaction. Wallace also advised teams from 14 health care delivery organizations across northwestern Ontario, Canada to reorganize care delivery around patient needs. In a large midwestern U.S. hospital system, Wallace teamed with the senior leaders to teach and implement the use of the Experience Group research tool. Facilitators from the hospital system now work with medically-defined segments of patients to determine whether newly created care paths provide the services those patients need in order to attain their best health.

Prior to his University affiliations, Wallace was the first president and CEO of the National Alliance for Health Information Technology, an organization committed to creating a safer, more efficient and unified health care system through IT. He is the co-founder of the Certification Commission for Healthcare Information Technology, the leading health care IT certification body, and was appointed by President George W. Bush to chair the Commission on Systemic Interoperability – a Federal Commission created to advise the White House and Congress on health transformation through IT. Prior to his commitment to health care, Wallace was CEO of a successful specialty chemical company that grew 10-fold during his tenure. He began his career working in corporate law and venture capital.

Wallace speaks, publishes and consults internationally on health IT, policy, chronic care models, outcomes measurement, innovation and financing issues in health care. He holds a juris doctorate from the University of Chicago Law School, a master’s degree with honors in business administration from the University of Chicago Graduate School of Business, and has a bachelor’s degree in economics from Duke University.



Capability, Comfort and Calm: Measuring What Matters Most

New Zealand’s national health strategy contemplates a transformation to value-based, team delivered care and has similarities with value-based reform initiatives underway around the world. This presentation will use a variety of new frameworks and international case studies to demonstrate how New Zealand can begin improving health outcomes by implementing value-based care delivery. The frameworks start by organizing care around segments of patients defined by their medical circumstances and health needs, building solutions to those needs, constructing teams that can effectively and efficiently deliver the solutions and measuring both the outcomes that matter most to patients and the costs of delivering the solutions. The transformation task relies heavily on the involvement of each community in the health care ecosystem, with device and pharmaceutical companies uniquely positioned to demonstrate the value of their products and services.